Dudediligence.

Stablecoin Development Corporat

SDEVAMEX · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$9.8MDec ’24$0.00Mar ’25$521,000Sep ’25$2.5MMar ’26$2.2MJun ’26
Net income, by quarter
−$1.2MSep ’24−$1.2MDec ’24$7.7MMar ’25−$1.9MJun ’25−$1.3MSep ’25−$635.2MDec ’25$552.4MMar ’26−$41.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$10.2M$14.4M$10.5M$9.8Mnone on file
Gross profit$6.5M$7.8M$6.1M$6.5Mnone on file
Operating income−$8.9M−$14.4M−$4.1M−$7.4M−$8.4M
Net income−$5.8M−$10.6M−$9.6M−$7.2M−$630.8M
Operating cash flow−$9.2M−$6.7M−$4.1M−$7.5M−$8.4M
Free cash flow−$9.2M−$6.8M−$4.2M−$7.5Mnone on file
Cash$7.5M$5.4M$2.9M$430,000$8.0M
Shares outstanding1.4M2.0M321.0K977.0K25.2M